공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

Drug Discovery 아웃소싱 시장 규모, 점유율, 동향 분석 : 워크플로우(리드 식별 및 후보 최적화, 기타), 치료 분야(종양, 호흡기), 약제 유형, 지역별 예측(2021-2028년)

Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow (Lead Identification & Candidate Optimization, Others), By Therapeutics Area (Oncology, Respiratory System), By Drug Type, And Segment Forecasts, 2021 - 2028

리서치사 Grand View Research, Inc.
발행일 2021년 02월 상품 코드 989682
페이지 정보 영문 128 Pages
가격
US $ 5,950 ₩ 6,725,000 Unprintable PDF (Single User License)
US $ 6,950 ₩ 7,855,000 Printable PDF (5-User License)
US $ 8,950 ₩ 10,116,000 Printable PDF (Enterprise License)


Drug Discovery 아웃소싱 시장 규모, 점유율, 동향 분석 : 워크플로우(리드 식별 및 후보 최적화, 기타), 치료 분야(종양, 호흡기), 약제 유형, 지역별 예측(2021-2028년) Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow (Lead Identification & Candidate Optimization, Others), By Therapeutics Area (Oncology, Respiratory System), By Drug Type, And Segment Forecasts, 2021 - 2028
발행일 : 2021년 02월 페이지 정보 : 영문 128 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 Drug Discovery 아웃소싱 시장 규모는 예측 기간 중 7.4%의 CAGR로 추이하며, 2028년에는 54억 달러 규모로 성장할 것으로 예측됩니다. 고액의 R&D비, 베스트셀러약의 특허 만료, Drug Discovery 프로세스의 스피드업에 대한 요구 등의 요인이 이 시장의 성장을 촉진할 전망입니다.

세계의 Drug Discovery 아웃소싱 시장을 조사했으며, 시장의 정의와 개요, 밸류체인, 시장 성장에 대한 각종 영향요인 분석, 시장 규모의 추이·예측, 워크플로우·치료 분야·약제 유형·지역/주요 국가 등 각종 부문별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

제1장 조사 방법·조사 범위

제2장 개요

제3장 시장 가변 요인·동향·전망

  • 보급·성장 전망 지도제작
  • 산업의 밸류체인
  • 시장 역학
  • 시장 분석 툴

제4장 시장 예측·동향 분석 : 워크플로우별

  • 대시보드
  • 시장 점유율 실적·예측
  • 시장 규모의 추이·예측
  • 타깃 식별·스크리닝
  • 타깃 검증·기능 인포매틱스
  • 리드 식별·후보 최적화
  • 전임상 개발
  • 기타

제5장 시장 예측·동향 분석 : 치료 분야별

  • 대시보드
  • 시장 점유율 실적·예측
  • 시장 규모의 추이·예측
  • 호흡기
  • 통증·마취
  • 종양
  • 안과
  • 혈액
  • 심장혈관
  • 내분비
  • 위장
  • 면역 조절
  • 항감염증
  • 중추신경계
  • 피부과
  • 비뇨생식기

제6장 시장 예측·동향 분석 : 약제 유형별

  • 대시보드
  • 시장 점유율 실적·예측
  • 시장 규모의 추이·예측
  • 소분자
  • 고분자(바이오의약품)

제7장 시장 예측·동향 분석 : 지역·주요 국가별

  • 대시보드
  • 시장 점유율 실적·예측
  • 시장 규모의 추이·예측
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
  • 아시아태평양
    • 일본
    • 중국
  • 라틴아메리카
    • 브라질
  • 중동·아프리카
    • 남아프리카공화국

제8장 경쟁 구도

  • 주요 기업·최근 개발·영향 분석
KSA 21.02.23

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 List of Secondary Sources
  • Table 3 Global Drug Discovery Outsourcing Market, by Region 2016 - 2028 (USD Million)
  • Table 4 Global Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 5 Global Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 6 Global Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 7 North America Drug Discovery Outsourcing Market, by Country, 2016 - 2028 (USD Million)
  • Table 8 North America Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 9 North America Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 10 North America Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 11 The U.S. Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 12 The U.S. Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 13 The U.S. Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 14 Canada Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 15 Canada Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 16 Canada Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 17 Europe Drug Discovery Outsourcing Market, by Country, 2016 - 2028 (USD Million)
  • Table 18 Europe Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 19 Europe Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 20 Europe Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 21 The U.K. Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 22 The U.K. Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 23 The U.K. Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 24 Germany Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 25 Germany Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 26 Germany Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 27 Asia Pacific Drug Discovery Outsourcing Market, by Country, 2016 - 2028 (USD Million)
  • Table 28 Asia Pacific Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 29 Asia Pacific Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 30 Asia Pacific Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 31 Japan Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 32 Japan Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 33 Japan Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 34 China Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 35 China Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 36 China Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 37 Latin America Drug Discovery Outsourcing Market, by Country, 2016 - 2028 (USD Million)
  • Table 38 Latin America Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 39 Latin America Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 40 Latin America Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 41 Brazil Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 42 Brazil Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 43 Brazil Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 44 MEA Drug Discovery Outsourcing Market, by Country, 2016 - 2028 (USD Million)
  • Table 45 MEA Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 46 MEA Drug Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 47 MEA Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)
  • Table 48 South Africa Drug Discovery Outsourcing Market, by Workflow, 2016 - 2028 (USD Million)
  • Table 49 South Africa Discovery Outsourcing Market, by Therapeutics Area, 2016 - 2028 (USD Million)
  • Table 50 South Africa Drug Discovery Outsourcing Market, by Drug Type, 2016 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Drug Discovery Outsourcing market :Market snapshot
  • Fig. 9 Drug Discovery Outsourcing market :Market segmentation
  • Fig. 10 Drug Discovery Outsourcing market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Drug Discovery Outsourcing market driver impact
  • Fig. 14 Drug Discovery Outsourcing market restraint impact
  • Fig. 15 Drug Discovery Outsourcing market porter's five forces analysis
  • Fig. 16 Drug Discovery Outsourcing market PESTEL analysis
  • Fig. 17 Drug Discovery Outsourcing market segment dashboard
  • Fig. 18 Drug Discovery Outsourcing market: workflow movement Analysis
  • Fig. 19 Target identification & screening drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 20 Target validation & functional informatics drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 21 Lead identification & candidate optimization drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 22 Preclinical development drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 23 Other associated workflow drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 24 Drug Discovery Outsourcing market segment dashboard
  • Fig. 25 Respiratory system drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 26 Pain and anesthesia drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 27 Oncology drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 28 Ophthalmology drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 29 Hematology drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 30 Cardiovascular drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 31 Endocrine drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 32 Gastrointestinal drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 33 Immunomodulation drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 34 Anti-infective drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 35 Central nervous system drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 36 Dermatology drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 37 Dermatology drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 38 Genitourinary system drug discovery outsourcing market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 39 Global drug discovery outsourcing market: Regional movement analysis
  • Fig. 40 Global market share, by region
  • Fig. 41 North America market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 42 The U.S. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 43 Canada market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 44 Europe market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 45 The U.K. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 46 Germany market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 47 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 48 Japan market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 49 China market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 50 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 51 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 52 Middle East and Africa market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 53 South Africa market estimates and forecast, 2016 - 2028 (USD Million)

Drug Discovery Outsourcing Market Growth & Trends

The global drug discovery outsourcing market size is expected to reach USD 5.4 billion by 2028 registering a CAGR of 7.4% over the forecast period, according to a new report by Grand View Research, Inc. Drug discovery is a costly and lengthy process. This has forced pharmaceutical and biotech companies to opt for outsourcing their research activities to academic and private Contract Research Organizations (CROs). Thus, factors such as high R&D costs, patent expiration of best-selling drugs, and the need to speed up the drug discovery process, are expected to boost the demand for outsourcing of drug discovery in the coming years.

Rising cases of chronic diseases have compelled companies to develop better medicines. Some of the key therapeutic areas where companies are actively involved in outsourcing include oncology, cardiovascular, and anti-infectives. In November 2020, AstraZeneca collaborated with 9 of the foremost oncology medical centers to expedite research in some of the hardest-to-treat cancers. The company will be funding clinical and non-clinical research proposals from members within this network. The COVID-19 pandemic has brought pharmaceutical companies in limelight. It is demonstrating the value of drug discovery and development.

Several companies are proactively involved in developing an effective vaccine to treat the disease. Pfizer Inc. and BioNTech SE received the first approval for the vaccine following a worldwide Phase 3 trial of a potential strain to combat the virus. As for clinical trials, many of them are halted, while some are functional by adopting remote monitoring technologies. Thus, the pandemic has brought the pharmaceutical industry to center-stage, with drug discovery outsourcing becoming a key aspect to develop effective treatments against the virus. This is expected to boost the market revenue for the next 2 years i.e. a short-term boom, after which it shall regain its original growth curve.

Drug Discovery Outsourcing Market Report Highlights

  • Lead identification & candidate optimization was the dominant workflow segment of the global market in 2020
  • The segment will retain its leading position throughout the forecast period as lead identification & candidate optimization is one of the critical processes in drug discovery
  • The oncology therapeutics area segment is projected to register the fastest CAGR from 2021 to 2028
  • The small molecules drug type segment led the market in 2020 and is also projected to record the fastest growth rate during the forecast period. This, however, may change in the short term with a higher emphasis on biologics
  • In terms of revenue share, North America is estimated to be the leading regional market during the forecast period
  • However, Asia Pacific is projected to be the fastest-growing regional market from 2021 to 2028 owing to government initiatives to forge alliances with the U.S. pharmaceutical companies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Workflow
    • 1.1.2. Therapeutics Area
    • 1.1.3. Drug Type
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:
    • 1.9.3. Objective 3:
    • 1.9.4. Objective 4:

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Discovery Outsourcing Market Variables, Trends & Scope

  • 3.1. Penetration & Growth Prospect Mapping
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Reimbursement framework
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
    • 3.3.3. Industry challenges
  • 3.4. Drug Discovery Outsourcing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis
    • 3.4.4. Market Entry Strategies

Chapter 4. Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Definitions and Scope
  • 4.3. Drug Discovery Outsourcing Market Share, 2020 & 2028
  • 4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 4.4.1. Target Identification & Screening
    • 4.4.2. Target Validation & Functional Informatics
    • 4.4.3. Lead Identification & Candidate Optimization
    • 4.4.4. Preclinical Development
    • 4.4.5. Other Associated Workflow

Chapter 5. Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Definitions and Scope
  • 5.3. Drug Discovery Outsourcing Market Share, 2020 & 2028
  • 5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 5.4.1. Respiratory System
    • 5.4.2. Pain & Anesthesia
    • 5.4.3. Oncology
    • 5.4.4. Ophthalmology
    • 5.4.5. Hematology
    • 5.4.6. Cardiovascular
    • 5.4.7. Endocrine
    • 5.4.8. Gastrointestinal
    • 5.4.9. Immunomodulation
    • 5.4.10. Anti-Infective
    • 5.4.11. Central Nervous System
    • 5.4.12. Dermatology
    • 5.4.13. Genitourinary System

Chapter 6. Drug Discovery Outsourcing Market: Drug Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Definitions and Scope
  • 6.3. Drug Discovery Outsourcing Market Share, 2020 & 2028
  • 6.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 6.4.1. Small Molecules
    • 6.4.2. Large Molecules (Biopharmaceuticals)

Chapter 7. Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2020 & 2028
  • 7.3. Regional Market Share, 2020
  • 7.4. North America
    • 7.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 7.4.2. The U.S.
      • 7.4.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 7.5.2. The U.K.
      • 7.5.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
    • 8.1.1. Albany Molecular Research Inc.
      • 8.1.1.1. Company overview
      • 8.1.1.2. Financial performance
      • 8.1.1.3. Product benchmarking
      • 8.1.1.4. Strategic initiatives
    • 8.1.2. EVOTEC
      • 8.1.2.1. Company overview
      • 8.1.2.2. Financial performance
      • 8.1.2.3. Product benchmarking
      • 8.1.2.4. Strategic initiatives
    • 8.1.3. Laboratory Corporation of America Holdings
      • 8.1.3.1. Company overview
      • 8.1.3.2. Financial performance
      • 8.1.3.3. Product benchmarking
      • 8.1.3.4. Strategic initiatives
    • 8.1.4. GenScript
      • 8.1.4.1. Company overview
      • 8.1.4.2. Financial performance
      • 8.1.4.3. Product benchmarking
      • 8.1.4.4. Strategic initiatives
    • 8.1.5. PPD Inc
      • 8.1.5.1. Company overview
      • 8.1.5.2. Financial performance
      • 8.1.5.3. Product benchmarking
      • 8.1.5.4. Strategic initiatives
    • 8.1.6. Charles River
      • 8.1.6.1. Company overview
      • 8.1.6.2. Financial performance
      • 8.1.6.3. Product benchmarking
      • 8.1.6.4. Strategic initiatives
    • 8.1.7. WuXi AppTec
      • 8.1.7.1. Company overview
      • 8.1.7.2. Financial performance
      • 8.1.7.3. Product benchmarking
      • 8.1.7.4. Strategic initiatives
    • 8.1.8. Merck & Co., Inc.
      • 8.1.8.1. Company overview
      • 8.1.8.2. Financial performance
      • 8.1.8.3. Product benchmarking
      • 8.1.8.4. Strategic initiatives
    • 8.1.9. Thermo Fisher Scientific Inc.
      • 8.1.9.1. Company overview
      • 8.1.9.2. Financial performance
      • 8.1.9.3. Product benchmarking
      • 8.1.9.4. Strategic initiatives
    • 8.1.10. Dalton Pharma Services
      • 8.1.10.1. Company overview
      • 8.1.10.2. Financial performance
      • 8.1.10.3. Product benchmarking
      • 8.1.10.4. Strategic initiatives
    • 8.1.11. Oncodesign
      • 8.1.11.1. Company overview
      • 8.1.11.2. Financial performance
      • 8.1.11.3. Product benchmarking
      • 8.1.11.4. Strategic initiatives
    • 8.1.12. Jubilant Biosys
      • 8.1.12.1. Company overview
      • 8.1.12.2. Financial performance
      • 8.1.12.3. Product benchmarking
      • 8.1.12.4. Strategic initiatives
    • 8.1.13. DiscoverX Corporation
      • 8.1.13.1. Company overview
      • 8.1.13.2. Financial performance
      • 8.1.13.3. Product benchmarking
      • 8.1.13.4. Strategic initiatives
    • 8.1.14. QIAGEN
      • 8.1.14.1. Company overview
      • 8.1.14.2. Financial performance
      • 8.1.14.3. Product benchmarking
      • 8.1.14.4. Strategic initiatives
Back to Top
전화 문의
F A Q